TCTR202103110010UnknownPhase 2
Efficacy of Bacillus clausii in Childhood Constipation: A Randomized, Double-Blind, Placebo Controlled Trial
Faculty of Medicine Ramathibodi Hospital0 sites62 target enrollmentStarted: March 11, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Sponsor
- Enrollment
- 62
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 Years to 5 Years (—)
- Sex
- All
Inclusion Criteria
- •Children age 1-5 years with constipation according to ROME IV criteria at Ramathibodi hospital
Exclusion Criteria
- •Organic causes of constipation, receive medication causing constipation,
- •immune deficiency, severe neurological or cardiac anomalies
Investigators
Similar Trials
Unknown
Not Applicable
Treatment of Chronic Constipation in Children With Lactobacillus ReuteriConstipationNCT01629147Sheba Medical Center40
Completed
Not Applicable
The study to explore the effect of Bacillus calusii and Bacillus Coagulans (the Probiotics) on Covid-19 disease progression in addition to routine Covid-19 treatment.CTRI/2021/03/031720Dr Mehdi Ali Mirza56
Completed
Not Applicable
Effect of Lactobacillus brevis KB290 on constipation and on microbiota of people who tend to be constipated.people tend to be constipatedJPRN-UMIN000014085Kagome Co., Ltd.60
Completed
Phase 4
Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American ChildrenAcute GastroenteritisNCT02169817Sanofi629
Unknown
Phase 4
Lactobacillus Reuteri in Children With ConstipationFunctional ConstipationNCT01388712Children's Memorial Health Institute, Poland128